The Antimicrobial Susceptibility Testing market is estimated to be valued at US$ 3,525.75 Mn in 2022 and is expected to exhibit a CAGR Of 6.4% Over The Forecast Period 2022-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Antimicrobial Susceptibility Testing involves determining the effectiveness of antimicrobial drugs against specific bacteria or fungi. It plays a crucial role in guiding appropriate antibiotic therapy, especially with the emergence of antimicrobial resistance. The growing prevalence of drug-resistant infections and the need for targeted therapy are driving the demand for Antimicrobial Susceptibility Testing worldwide. The market offers a wide range of products such as automated systems, manual testing products, and consumables for accurate and reliable testing. These tests are extensively used in various healthcare settings, including hospitals, diagnostic laboratories, and research institutes.

Market Dynamics:
The Antimicrobial Susceptibility Testing market is driven by two main factors. Firstly, the rising prevalence of antimicrobial resistance is increasing the demand for effective testing methods to guide appropriate antibiotic therapy. With the overuse and misuse of antibiotics, bacteria and fungi are evolving and developing resistance, making treatment difficult. Secondly, technological advancements in testing methods and equipment are driving market growth. Automated systems and rapid diagnostic tests are gaining popularity due to their ability to provide accurate and timely results, improving patient outcomes. The market is witnessing a shift towards molecular diagnostics and next-generation sequencing, which offer faster and more comprehensive testing capabilities.

Read More : https://cmiorientedreportblog.blogspot.com/2023/10/antimicrobial-susceptibility-testing.html